In case you missed it: Aug 1 to Aug 5


A look back at the week's news.

Cervical cancer screening guidelines for adolescents

Teenaged girls at average risk don’t need Papanicolaou tests, but some special populations do.

Finding the best fit

Best practices on discussing birth control for adolescents.

FDA grants ibrexafungerp sNDA priority review for RVVC

If approved, ibrexafungerp would be the first and only approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent vulvovaginal candidiasis (RVVC).

The latest resources from the American Urogynecologic Society

Check out these latest resources from the American Urogynecologic Society.

New ICD-10 codes to know before October

Changes for ICD-10 documentation codes that go into effect in October 2022.

How much money are you losing in unnecessary meetings?

Tips to avoid wasting time and optimize meetings you do need.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit:
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit:
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
Related Content
© 2024 MJH Life Sciences

All rights reserved.